Akkermansia and targeted synbiotic inputs support your body's endogenous GLP-1 signalling — helping regulate satiety, reduce cravings, and put you back in control of hunger without pharmaceutical intervention.
Built to Support Natural GLP-1 Activity
Precision formulated to activate your body's own appetite control, metabolic efficiency, and long-term weight management
Hear it from our community
-
GLP1BIOTICS™
Didn't want a prescription, wanted a system.
The injection wasn't for me — the cost, the needles, all of it. This was the upstream route I was looking for. My cravings are calmer, my energy's steadier through the day, and digestion sorted itself out in the first couple weeks too.
Chris S. Verified customer -
GLP1BIOTICS™
Glucose rollercoaster, gone.
I used to eat and then need a nap an hour later. Now meals don't knock me out. Whatever it's doing with how my body handles food, it feels smoother — more stable energy, fewer cravings between meals.
Amanda F. Verified customer -
GLP1BIOTICS™
Taking it alongside my protocol.
I'm still on my GLP-1, but the GI side effects were rough and I'd read about muscle loss being a thing. Added this for gut support and I've noticed my digestion is a lot calmer on injection days. Feels like it's covering the gaps the drug doesn't touch.
Vanessa C. Verified customer -
GLP1BIOTICS™
Came off the injection, didn't want the rebound.
I finished my GLP-1 protocol and was honestly scared of the bounce-back everyone warns about. Started this as my maintenance plan. A few months in and my appetite still feels regulated — like my body's doing the work itself now. That was the whole point for me.
Renata S. Verified customer -
GLP1BIOTICS™
Regular, finally.
I'll spare the details, but things are working the way they're supposed to now. Consistent, comfortable, no more guessing how my stomach's going to feel after lunch. Quietly one of the best parts.
Ben K. Verified customer
91%
reported reduced cravings and better appetite control within the first 2–3 weeks of daily use.
86%
experienced more stable energy and fewer sugar crashes without pharmaceutical intervention.
90%
reported less bloating and improved digestive comfort during their weight management journey.
84%
experienced more stable energy and fewer post-meal crashes without relying on stimulants.
*Based on consumer study (n=66) after 4 weeks of daily use
Enteric Encapsulation Technology
Engineered to Maximize Bioavailability
1. Precision Synbiotic Formulation
Every capsule delivers a targeted stack of Akkermansia, B. breve BBr60™, tributyrin, and inulin — precision-dosed to support natural GLP-1 activity, gut integrity, and metabolic signaling in a single daily serve.
2. Enteric-Protected Delivery
An acid-resistant enteric capsule shields every active ingredient from stomach acid — ensuring probiotics, postbiotics, and prebiotics arrive intact and alive in the lower intestine, exactly where GLP-1 signalling begins.
3. Maximized Strain Viability
Standard capsules lose a significant portion of live cultures to gastric breakdown before they ever reach the gut. Enteric protection eliminates this loss, so every evidence-based dosage performs at full potency.
2. Enteric-Protected Delivery
An acid-resistant enteric capsule shields every active ingredient from stomach acid — ensuring probiotics, postbiotics, and prebiotics arrive intact and alive in the lower intestine, exactly where GLP-1 signalling begins.
3. Maximized Strain Viability
Standard capsules lose a significant portion of live cultures to gastric breakdown before they ever reach the gut. Enteric protection eliminates this loss, so every evidence-based dosage performs at full potency.
4. Engineered for Absorption, Not Redundancy
No fillers. No over-dosing to compensate for poor delivery. GLP1Biotics™ is formulated to work with your gut biology — delivering the right actives, to the right place, at the right time.
GLP1Biotics™ supports endogenous GLP-1 signaling at the microbial level — without pharmaceutical stimulation.
Research-backed Ingredients Optimized for Metabolic Performance and Endogenous GLP-1 Signaling
-
Akkermansia muciniphila AKK11™
The keystone strain behind your body's own GLP-1 — the gut signal that tells you you're full
Appetite Control · Gut Barrier · Glucose Balance
-
Bifidobacterium breve BBr60™
A clinically studied strain that helps balance the microbiome behind cravings and weight
Cravings · Microbiome Balance · Digestive Health
-
Tributyrin
Bioavailable butyrate that fuels the gut cells responsible for GLP-1 signaling
Gut Fuel · Metabolic Support · Low Inflammation
-
Chicory inulin
Prebiotic fiber that feeds your good bacteria and keeps the whole system fed
Prebiotic Fuel · Digestive Health · Strain Support
Akkermansia muciniphila AKK11™
Science
- Clinically studied for supporting insulin sensitivity and metabolic markers
- Supports gut barrier function, relevant to systemic metabolic inflammation
- Associated with healthier body composition and glucose control in targeted populations
- Benefits may depend on baseline levels and formulation (a precision-microbiome concept)
Clinical Studies
- Depommier et al. (2019) — Nature Medicine."Supplementation with Akkermansia muciniphila in overweight and obese human volunteers."
- Plovier et al. (2017) — Nature Medicine."A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice"
- Cani et al. (2022) — Gut Microbes (Comprehensive Review)."Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms"
- Anhê et al. (2021) — Cell Metabolism. "Enteroendocrine-derived glucagon-like peptide-1 drives improvements of glucose homeostasis by pasteurized Akkermansia muciniphila"
Bifidobacterium breve BBr60™
Science
- In human trials, associated with improvements in weight/BMI and metabolic markers in overweight/obese adults
- Studied for effects on glucose-related biomarkers and broader metabolic profiles
- Mechanistic evidence links microbiome shifts to SCFAs and metabolic hormone signaling (including GLP-1 network markers)
- Supports a gut environment aligned with long-term metabolic health
Clinical Studies
- Bai Z. et al. (2024). Gut Microbiome and Metabolome Alterations in Overweight or Obese Adult Population after Weight-Loss Bifidobacterium breve BBr60 Intervention: A Randomized Controlled Trial. International Journal of Molecular Sciences.
- Gao D. et al. (2025). Bifidobacterium Breve BBr60 Improves Obesity Via the Gut Microbiota–Short-Chain Fatty Acid–IL-27/GLP-1 Axis: Evidence from a Randomized, Double-Blind, Placebo-Controlled Trial. Probiotics and Antimicrobial Proteins.
Tributyrin
Science
- Supports gut barrier integrity and intestinal lining resilience
- Helps maintain a healthier inflammatory tone, relevant to metabolic function
- In human trials, tributyrin-based delivery can increase systemic butyrate availability
- Supports metabolic flexibility via gut-derived signaling
Clinical Studies
- van Deuren T. et al. (2023). Butyrate and hexanoate-enriched triglycerides increase postprandial systemic butyrate and hexanoate in men with overweight/obesity: A double-blind placebo-controlled randomized crossover trial. Frontiers in Nutrition.
- Smith M.M. et al. (2024). Investigation of the tolerability and potential health benefits of a novel butyrate-generating supplement in a pilot human study. Nutrition and Healthy Aging.
Chicory inulin
Science
- Clinically linked to improvements in weight-management markers (e.g., body weight, waist circumference)
- upports satiety signaling through gut fermentation products
- May help support glucose control and insulin regulation in metabolic contexts
- Promotes a gut environment that supports beneficial microbes tied to metabolic health
Clinical Studies
- Reimer R.A. et al. (2024). The effects of chicory inulin-type fructans supplementation on weight management outcomes: systematic review, meta-analysis, and meta-regression of randomized controlled trials. (Systematic review/meta-analysis).
- Guess N.D. et al. (2015). A randomized controlled trial: the effect of inulin on weight management and ectopic fat in subjects with prediabetes. (Randomized controlled trial).
- Aliasgharzadeh A. et al. (2015). A Combination of Prebiotic Inulin and Oligofructose Improve Some of Cardiovascular Disease Risk Factors in Women with Type 2 Diabetes: A Randomized Controlled Clinical Trial.
Not All Weight Solutions Are Built Alike
Most weight management options force a trade-off — pharmaceutical side effects, stimulant crashes, or generic formulas that never reach the gut. GLP1Biotics™ is engineered differently: targeting appetite, glucose, and body composition at the microbial level, where long-term weight regulation actually begins.
|
|
GLP1Biotics™
|
GLP-1 Drugs
|
Traditional Fat Burners
|
|---|---|---|---|
|
Activates Natural GLP-1 Pathways
|
|
|
|
|
Supports Glucose Balance & Insulin Sensitivity
|
|
|
rare
|
|
Microbiome Precision Formula (Akkermansia, BBr60)
|
|
|
rare
|
|
Butyrate-Driven Metabolic Signaling
|
|
|
|
|
Designed for Sustainable Daily Use
|
|
|
some
|
|
No Dependency or Rebound Risk
|
|
|
|
|
Supports Gut Health Simultaneously
|
|
|
rare
|
|
Drug-Free Approach
|
|
|
|
Designed Sustainably. Delivered Monthly.
Our refill system is engineered to preserve the integrity of your Archemi formula while minimizing waste and respecting the planet we share.
Welcome Kit
First shipment- Free refillable glass bottle
- Free travel vial
- 30-day (90-day) supply - monthly (quarterly) subscription
Refills
Subsequent shipment- Monthly or quarterly refills
Start with confidence — get clear on the details.
GLP1Biotics™ is a precision synbiotic formulated to support healthy weight management, glucose balance, and long-term metabolic health.
It combines Akkermansia, B. breve BBr60™, tributyrin, and inulin to target the gut–metabolic axis — the microbial layer involved in appetite regulation, insulin response, and energy utilization.
GLP1Biotics™ supports metabolic regulation through multiple gut-driven pathways:
- Akkermansia supports endogenous GLP-1 and metabolic signaling
- B. breve BBr60™ supports microbiome balance linked to weight regulation
- Tributyrin delivers a bioavailable precursor to butyrate, supporting metabolic communication and inflammation balance
- Inulin nourishes beneficial bacteria to enhance microbial diversity
Together, these ingredients support your body’s natural GLP-1 signaling and glucose response — without pharmaceutical stimulation.
No. GLP1Biotics™ is not a drug and does not contain semaglutide or pharmaceutical GLP-1 analogs.
Instead of mimicking GLP-1 pharmacologically, it supports the gut mechanisms involved in natural GLP-1 signaling.
Most weight supplements rely on stimulants or thermogenic compounds.
GLP1Biotics™ is:
- Stimulant-free
- Microbiome-focused
- Designed for metabolic balance rather than short-term appetite suppression
It supports sustainable metabolic health instead of forcing rapid results.
Standard probiotics primarily target digestion.
GLP1Biotics™ is formulated specifically for metabolic function, featuring:
- Clinically studied strains associated with weight modulation
- Akkermansia, a next-generation strain linked to metabolic health and endogenous GLP-1 signaling
- Tributyrin, a direct butyrate precursor rarely found in conventional probiotics
This is a next-generation synbiotic targeting endogenous GLP-1 signaling at the microbial level — beyond basic gut support
Every body is unique, but typical timelines:
- Days 1–7: improved digestive comfort and early appetite awareness. Some users notice feeling fuller after meals
- Weeks 2-4: reduced cravings and fewer energy crashes between meals. More stable daily energy patterns
- Weeks 4–8: stronger satiety signaling and improved portion control. Better consistency in weight-management habits
- Weeks 8-10: deeper metabolic support as the microbiome shifts — supporting glucose balance, appetite regulation, and long-term body composition goals
GLP1Biotics™ is designed for sustained metabolic modulation — not rapid, stimulant-driven weight loss.
Yes. GLP1Biotics™ is designed for daily use to support long-term metabolic health.
Yes. The formula includes:
- Akkermansia muciniphila AKK11™
- Bifidobacterium breve BBr60™
These strains have been studied for their roles in endogenous GLP-1 signaling, glucose control, metabolic and microbiome modulation.
Adults take one capsule daily with food.
Yes — the capsule and all ingredients are vegan-friendly.
No — the strains and formulation are shelf-stable. Store in a cool, dry place away from direct sunlight.